151 related articles for article (PubMed ID: 12052691)
1. Release of ketoprofen enantiomers from HPMC K100M matrices--diffusion studies.
Solinís MA; de la Cruz Y; Hernández RM; Gascón AR; Calvo B; Pedraz JL
Int J Pharm; 2002 Jun; 239(1-2):61-8. PubMed ID: 12052691
[TBL] [Abstract][Full Text] [Related]
2. Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives.
Solinís MA; de la Cruz Y; Calvo B; Hernández RM; Gascón AR; Goñi I; Gurruchaga MD; Pedraz JL
Chirality; 2002 Nov; 14(10):806-13. PubMed ID: 12395398
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
4. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of drug release in citrate buffered HPMC matrices.
Pygall SR; Kujawinski S; Timmins P; Melia CD
Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
[TBL] [Abstract][Full Text] [Related]
6. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
[TBL] [Abstract][Full Text] [Related]
7. Formulation of biphasic release tablets containing slightly soluble drugs.
Maggi L; Machiste EO; Torre ML; Conte U
Eur J Pharm Biopharm; 1999 Jul; 48(1):37-42. PubMed ID: 10477326
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective drug release from ketoprofen and ricobendazole matrix tablets.
Alvarez C; Torrado JJ; Cadórniga R
Chirality; 1999; 11(8):611-5. PubMed ID: 10467311
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
Odeku OA; Fell JT
J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
[TBL] [Abstract][Full Text] [Related]
11. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
McConville JT; Ross AC; Florence AJ; Stevens HN
Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
[TBL] [Abstract][Full Text] [Related]
12. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
13. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
14. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.
Alshetaili AS; Almutairy BK; Tiwari RV; Morott JT; Alshehri SM; Feng X; Alsulays BB; Park JB; Zhang F; Repka MA
Curr Drug Deliv; 2016; 13(5):730-41. PubMed ID: 26456211
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and 1H-NMR study.
Srichana T; Suedee R
Drug Dev Ind Pharm; 2001 May; 27(5):457-64. PubMed ID: 11448053
[TBL] [Abstract][Full Text] [Related]
17. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
Wang SH; Liang ZH; Zeng S
Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
[TBL] [Abstract][Full Text] [Related]
18. Stereoselectivity evaluation of chiral chitosan microspheres delivery system containing rac-KET in vitro and in vivo.
Yin LN; Zhang YW; Huang WH; Wang SH; Zheng GL
Drug Deliv; 2019 Dec; 26(1):63-69. PubMed ID: 30744429
[TBL] [Abstract][Full Text] [Related]
19. Designing HPMC matrices with improved resistance to dissolved sugar.
Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
[TBL] [Abstract][Full Text] [Related]
20. A predictive model for the release of slightly water-soluble drugs from HPMC matrices.
Fu XC; Wang GP; Wang YH; Liang WQ
Pharmazie; 2004 Aug; 59(8):624-6. PubMed ID: 15378852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
